174900 — AbClon Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for AbClon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,375	2,771	3,018	3,406	3,083
Cost of Revenue
Gross Profit	12,999	1,213	1,618	2,379	2,208
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	10,092	9,343	13,247	12,156	14,753
Operating Profit	4,283	-6,571	-10,229	-8,750	-11,670
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,704	-6,445	-10,238	-10,349	-12,755
Provision for Income Taxes
Net Income After Taxes	2,567	-6,445	-10,238	-9,254	-12,766
Net Income Before Extraordinary Items
Net Income	2,567	-6,445	-10,238	-9,254	-12,766
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	2,567	-6,445	-10,238	-9,254	-12,766
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	179	-447	-670	-604	-824
Dividends per Share